INOD vs ITRN

INOD presents a stark contrast between a clean balance sheet and severe valuation and technical deterioration. With a Piotroski F-Score of 4/9 (Stable) and a Graham Number of $8.28, the stock is trading at a massive premium to its deterministic fair value. While the company maintains a very low debt-to-equity ratio (0.04) and strong ROE (37.76%), these are offset by negative earnings growth (-19.4% YoY) and a catastrophic 6-month price decline of 57.3%. The disconnect between the analyst target price ($91.25) and the current price action suggests a significant market correction is underway.

ITRN exhibits exceptional financial health with a Piotroski F-Score of 8/9, indicating strong operational efficiency and balance sheet strength. While the current price of $53.54 is a significant premium over the Graham Number ($26.84), it remains well below the growth-based intrinsic value of $67.31. The company combines steady double-digit growth with a highly attractive 11.21% dividend yield and negligible debt (D/E 0.02). Despite a bearish technical trend score and weak insider sentiment, the fundamental data suggests a high-quality compounder with significant margin of safety in its health metrics.